Outcomes of hyperbaric oxygen treatment for central and branch retinal artery occlusion at a major Australian referral hospital
Diving and Hyperbaric Medicine Journal · 2023
DOI: 10.28920/dhm53.3.224-229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diving and Hyperbaric Medicine Journal, 2023. Verfasst von Jeremy Williamson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Royal Brisbane and Women's Hospital, Brisbane, Australia. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Retinal Artery Occlusion. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
This study analysed the treatment outcomes of patients that received hyperbaric oxygen treatment (HBOT) for retinal artery occlusion (RAO) at the Royal Brisbane and Women’s Hospital in Brisbane, Australia between 2015 and 2021.
Methods
Retrospective study from patient records including 22 eyes from 22 patients that received HBOT for either central RAO (17 patients) or branch RAO (five patients). Patients received the Royal Brisbane and Women’s Hospital RAO protocol for their HBOT. Analysis included best corrected visual acuity pre- and post-treatment, subjective improvements, side effects and patient risk factors were also recorded.
Results
Improvement in best corrected visual acuity was LogMAR -0.2 for central RAO on average with 8/17 (47%) experiencing objective improvement, 5/17 (29%) experienced no change and 4/22 (24%) experienced a reduction in best corrected visual acuity. Subjective improvement (colour perception or visual fields) was reported in an additional 4/17 patients, resulting in 12/17 (71%) reporting improvement either in visual acuity or subjectively. There was no improvement in the best corrected visual acuity of any of the five patients suffering from branch RAO. Cardiovascular risk factors present in the cohort included hypertension, hypercholesterolaemia, previous cardiovascular events, cardiac disease and smoking. Limited side effects were experienced by this patient cohort with no recorded irreversible side effects.
Conclusions
Hyperbaric oxygen treatment appears a safe, beneficial treatment for central RAO. No benefit was demonstrated in branch RAO although numbers were small. Increased awareness of HBOT for RAO resulting in streamlined referrals and transfers and greater uptake of this intervention may further improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
- Department of Hyperbaric Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia.
- School of Medicine, University of Queensland, Brisbane, Australia.
- Corresponding author: Dr Thomas P Moloney, Department of Ophthalmology, Royal Brisbane and Women's Hospital, Brisbane, Australia, t.moloney@uq.edu.au.
Zitieren
APA
Williamson, J., Sharma, A., Murray-Douglass, A., Peters, M., Lee, L., Webb, R., Thistlethwaite, K., & Moloney, T. P. (2023). Outcomes of hyperbaric oxygen treatment for central and branch retinal artery occlusion at a major Australian referral hospital. Diving and Hyperbaric Medicine Journal. https://doi.org/10.28920/dhm53.3.224-229
Vancouver
Williamson J, Sharma A, Murray-Douglass A, Peters M, Lee L, Webb R, et al. Outcomes of hyperbaric oxygen treatment for central and branch retinal artery occlusion at a major Australian referral hospital. Diving and Hyperbaric Medicine Journal. 2023. doi:10.28920/dhm53.3.224-229
BibTeX
@article{Williamson2023,
author = {Williamson, Jeremy and Sharma, Anil and Murray-Douglass, Alexander and Peters, Matthew and Lee, Lawrence and Webb, Robert and Thistlethwaite, Kenneth and Moloney, Thomas P},
title = {Outcomes of hyperbaric oxygen treatment for central and branch retinal artery occlusion at a major Australian referral hospital},
journal = {Diving and Hyperbaric Medicine Journal},
year = {2023},
doi = {10.28920/dhm53.3.224-229}
}
EUVIMED